Enove products were recognized as patent-intensive products

Recently, the China Patent Protection Association announced the list of patent-intensive products for 2024 on the national patent-intensive product registration and recognition pilot platform. Nantong Enove Precision Plastics Catheter Co., Ltd.'s "Medical Interventional Plastic Catheter" product was recognized, marking that our company has taken a new step in R&D innovation, intellectual property protection, and transformation of high-tech achievements.

The filing and certification of patent-intensive products is carried out by the National Intellectual Property Administration in accordance with the requirements of the "Special Action Plan for Patent Transformation and Utilization (2023-2025)" of the General Office of the State Council. It focuses on the actual contribution of patents in improving product competitiveness and added value, and refers to the "Evaluation Method for Enterprise Patent-Intensive Products" (T/PPAC402-2022). It is a unified certification carried out by industry for products that meet the evaluation standards of their product classification, have high economic benefits and outstanding patent value contributions. It is of great significance to strengthen the cultivation of patent-intensive industries, promote patent-intensive products, and promote the transformation and effectiveness of patents at the product and industry ends.